Leukemia Research
Volume 24, Issue 4 , Pages 289-297 , April 2000

Characterization of two novel sublines established from a human megakaryoblastic leukemia cell line transfected with p210BCR-ABL

  • Ellin Berman

      Affiliations

    • Department of Medicine, The Laboratory of Hematopoietic Cell Kinetics, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    • Corresponding Author InformationCorresponding author. Leukemia Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA. Tel.: +1-212-6397762; fax: +1-212-7944338
    • ,
  • Suresh Jhanwar

      Affiliations

    • Department of Medicine, The Laboratory of Hematopoietic Cell Kinetics, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    • Department of Human Genetics, Cytogenetics Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    • ,
  • Mary McBride

      Affiliations

    • Department of Medicine, The Laboratory of Hematopoietic Cell Kinetics, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    • ,
  • Annabel Strife

      Affiliations

    • Department of Medicine, The Laboratory of Hematopoietic Cell Kinetics, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    • ,
  • David Wisniewski

      Affiliations

    • Department of Medicine, The Laboratory of Hematopoietic Cell Kinetics, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    • ,
  • Caryl Lambek

      Affiliations

    • Department of Medicine, The Laboratory of Hematopoietic Cell Kinetics, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    • ,
  • Bayard Clarkson

      Affiliations

    • Department of Medicine, The Laboratory of Hematopoietic Cell Kinetics, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA

Received 18 May 1999 ,Accepted 11 October 1999.

References 

  1. Fearon ER, Burke PJ, Schiffer CA, Zehnbauer BA, Vogelstein B. Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia. New Engl. J. Med. 1986;315:15
  2. List AF, Garewal HS, Sandberg AA. The myelodysplastic syndromes: biology and implications for management. J. Clin. Oncol. 1990;8:1424
  3. Lyall J, Garson DM. Non-random chromosome changes in the blastic transformation stage of Ph′ positive chronic myelogenous leukemia. Leuk. Res. 1978;2:213
  4. Konopka JA, Witte On. Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products. Mol Cell Biol 1985;5:3116.
  5. Daley GQ, Baltimore D. Transformation of an interleukin-3 dependent hematopoietic cell line by the chronic myelogenous leukemia-specific p210bcr-abl protein. Proc. Natl. Acad. Sci. USA. 1988;85:9312
  6. Heisterkamp N, Jenster G, ten Hoeve J, Zovich D, Pattengale P, Groffen J. Acute leukaemia in bcr/abl transgenic mice. Nature. 1990;344:251
  7. Daly GQ, van Etter RA, Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210 BCR/ABL gene of the Philadelphia chromosome. Science. 1990;247:824
  8. Pear WS, Miller JP, Xu L, et al.  Efficient and rapid induction of a CML-like myeloproliferative disease in mice receiving P210 bcr/abl transduced marrow. Blood. 1998;92:3780
  9. Miniero R, Madon E, Avanzi G, Saitta M, Forni M, Ghisolfi G, et al. Unusual cytogenetic, immunophenotypic and histochemical findings in a case of acute megakaryocytic leukemia. Haematologica. 1987;72:505
  10. Matsuguchi T, Salgia R, Hallek M, Eder M, Druker B, Ernst T, et al. Shc phosphorylaton in myeloid cells is regulated by granulocyte macrophage colony stimulating factor, interleukin-3, and Steel factor and is constitutively increased by p210bcr-abl. J. Biol. Chem. 1994;269:5016
  11. Avanzi G, Lista P, Giovinazzo B, Miniero R, Saglio G, Benetton G, et al. Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features. Br. J. Haematol. 1988;69:359
  12. Strife A, Lambek, Perez A, Darzynkiewwicz Z, Skierski J, Gulati S, Haley J, ten Dijke P, Iwata K, Clarkson B. The effects of transforming growth factor β-3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood. Cancer Res 1991;51:4828.
  13. Mohamed AN, Clarkson BD, Chaganti RSK. High resolution banding of chronic myeloid leukemia chromosomes. Cancer Genet. Cytogenet. 1986;20:209
  14. Mitelman F. An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: Karger; 1995;
  15. Presti JC, Rao PH, Chen Q, Reuter VE, Li FP, Fair W, et al. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res. 1991;51:1544
  16. Nakamura Y, Leppert M, O’Connell P, Wolfe R, Holm T, Culver M, et al. Variable number of tandem repeat (VNTR) markers for human gene mapping. Science. 1987;235:1616
  17. Kasai K, Nakamura Y, Whie R. Amplification of a variable number of tandem repeats (VNTR) locus(pMCT118) by the polymerase chain reaction (PCR) and its application to forensic science. J. Forensic. Sci. 1990;35:1196–1200
  18. Laneuville P, Sun G, Timm M, Vekemans M. Clonal evolution in a myeloid cell line transformed to interleukmin-3 independent growth by retroviral transduction and expression of p210bcr/abl. Blood. 1992;80:1788
  19. Nakahata T, Okumura N. Cell surface antigen expression in human erythroid progenitors: erythroid and megakaryocytic markers. Leuk. Lymph. 1994;13:401
  20. Endo K, Harigae H, Nagai T, Fujie H, MeguroK, Watanabe N, Furuyama K, Kameoka J, Okuda M, Hayashi N, Yamamoto M, Abe K. Two chronic myelogenous leukaemia cell lines which represent different stages of erythroid differentiation. Br J Haemat 1993;85:653.
  21. Wisniewski D, Strife A, Wojciechowicz D, Lambek C, Clarkson B. Rapid communication: a 62-kilodalton tyrosine phosphoprotein constitutively present in primary chronic phase chronic myelogenous leukemia enriched lineage negative blast populations. Leukemia. 1994;8:688
  22. Wisniewski D, Strife A, Berman E, Clarkson B. C-kit ligand stimulates tyrosine phosphorylation of a similar pattern of phosphotyrosyl proteins in primary normal hematopoietic progenitors that are constitutively phosphorylated in comparable primitive progenitors in chronic phase chronic myelogenous leukemia. Leukemia. 1996;10:229
  23. Wisniewski D, Strife A, Clarkson B. Rapid communication: c-kit ligand stimulates tyrosine phosphorylation of the c-Cbl protein in human hematopoietic cells. Leukemia. 1996;10:1436
  24. Carpino N, Wisniewski D, Strife A, Marshak D, Kobayashi R, Stillman B, et al. p62dok: a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell. 1997;88:197

PII: S0145-2126(99)00179-4

Leukemia Research
Volume 24, Issue 4 , Pages 289-297 , April 2000

Article Tools

* Image Usage & Resolution